Recombinant Human LTF (C-6His)

Description

EnkiLife provides the Recombinant Human LTF (C-6His) protein,aslo know as Lactotransferrin,Lactoferrin,Talalactoferrin,Kaliocin-1,Lactoferroxin-A,Lactoferroxin-B,Lactoferroxin-C,LTF,LF, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Lactotransferrin/LTF is produced by our Mammalian expression system and the target gene encoding Gly20-Lys711 is expressed with a 6His tag at the C-terminus.Accession:AAH15822.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:77.3 KDa. Background:Lactotransferrin is a member of the transferrin family that transfer iron to the cells and control the level of free iron in the blood and external secretions. Lactotransferrin is a secreted protein and contains two transferrin-like domains. Lactotransferrin can be cleaved into the following four chains: Kaliocin-1, Lactoferroxin-A, Lactoferroxin-B, and Lactoferroxin-C. Lactoferroxin A, Lactoferroxin B, and Lactoferroxin C have opioid antagonist activity. Lactoferroxin A shows preference for mu-receptors, while Lactoferroxin B and Lactoferroxin C have somewhat higher degrees of preference for kappa-receptors than for mu-receptors. LTF has antimicrobial activity (bacteriocide, fungicide) and is part of the innate defense, mainly at mucoses.